Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAAMH47902
Magnesium Glycinate Bisglycinate Haute dose 1422 mg + Vitamine B6 180 gélules Origine Angleterre (UK)
longtail
3P
MEDICAMENTS
Last 4 weeks demand
28
▼ 40.4% vs prev 4w
Offer Stock
4
Σ Stock across 2 live offers (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 286
avg of last 30 sells · latest 2026-09-28
AAAMH47902
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 237 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisglycinate Haute dose 1422 mg + Vitamine B6 180 gélules Origine Angleterre (UK) · in the longtail cohort · last 4 weeks 28 units, trending down -40.4% · on-hand 10 units
Signals the model saw
- Cohort: longtail (693 days of history, 222 units sold over 52 weeks)
- Volatility (CV): 0.97 — moderate
- Recent trend: last 4w = 28 units · prev 4w = 47 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 1.4 units |
| Realistic forecast — next 4 weeks | 4.9 units |
| Realistic forecast — next 3 months | 85.5 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 13.6 units |
| Optimistic — next week | 12.4 units |
| Optimistic — next 4 weeks (reorder target) | 49.4 units |
| Optimistic — next 3 months (quarterly PO target) | 237.5 units |
| Legacy μ/wk (reorder pipeline) | 4.9 |
| Revenue exposure — optimistic, 3 months | MAD 68.0K |